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Chimerism, Graft-Vs-Host Disease, Rejection, and Their Association 
With Reciprocal Donor-Host Immune Reactions After Cell, Organ, 
and Composite Tissue Transplantation 
R. Llull, N. Murase, Q. Ye, A.J. Demetris, and T.E. Starzl 
WE HAVE postulated that a small number of donor-derived leukocytes and the recipient immune sys-
tem mutually interact and reciprocally attenuate both host-
vs-graft (HVG) and graft-vs-host (GVH) reactions. I 
Multiple cell and organ transplant models confirm the 
coexistence of donor cell traffiking and graft acceptance.: 
However, the outcome of GVH and HVG reactions after 
drug discontinuation remains unpredictable. In this study. 
we hypothesize that both the graft's antigenicity and migra-
tory cell load playa determinant role in the development of 
chimerism, graft-vs-host disease (GVHD). and rejection 
during the final drug-free stage. 
MATERIALS AND METHODS 
BN recipients underwent different cell. organ, or composite tissue 
allografts from LEW donors. Immunosuppression involved short 
(28 days) or prolonged (100 days) treatment with tacrolimus (1 
mglkg/d 1M for 14 days. then weekly). Cell inoculi (spleen, bone 
marrow) and organ allografts (liver. heart. small bowel) were 
studied and compared to composite tissue allografts (eTA; rat hind 
limb) which conversely offer both a strong antigenic barrier as well 
as a continuous source of viable migratory donor leukocytes (ie, 
vascularized bone marrow).' 
RESULTS AND DISCUSSION 
Following short-term immunosuppression. tolerogenic allo-
grafts (bone marrow. liver) reached long-term survival and 
tissue-detectable microchimerism (Table 1). Only heart 
allografts. with high antigenicity and low migratory cell 
load, underwent moderate to severe chronic rejection and 
disappearance of mixed tissue microchimerism by flow 
cytometric techniques. Those allografts with a heavy migra-
tory cell load such as the bone marrow, spleen. and small 
bowel presented significant expansion of tissue and periph-
eral chimerism and concomitantly. the greatest incidence of 
GVHD. Bone marrow inoculi displayed low GVHD sus-
ceptibility. cr As. which are highly antigenic and contain 
the greatest viable migratory cell load. underwent delayed 
rejection after short-term immunosuppressive coverage. 
However. when exposed to prolonged immunosuppression. 
the chimeric expansion was allowed to stabilize throughout 
tacrolimus coverage. After its discontinuation. transient. 
nonlethal GVH reaction ensued in 9 of 13 animals. Their 
recovery was then consistently followed by slow reduction 
of cytometrically detectable chimeric leukocytes from pe-
ripheral blood. repopulation of the donor bone marrow 
with recipient elements. and allograft chronic rejection. Of 
notice, allografted hind limbs remained free of either GVH 
or rejection signs. These results emphasize the role of viable 
graft-contained migratory cells for the introduction of 
mechanisms of peripheral immunomodulation and GVHD 
induction. The relative antigenicity of the grafted tissue also 
seems to impact the survival of the peripheralized chimeric 
immunocytes since abolition of the chimeric component is 
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Table 1. Rejection, GVHD, and Chimerism After Short and Prolonged Immunosuppression 
Graft Survival Following 
Graft No Treatment Short Treatment Prolonged Treatment 
Bone marrow >100 >100 >100 
Uver 28.5 >100 >100 
Heart 8.0 >100 >100 
Spleen >100 60.0 75.5 
Intestine 12.0 43.0 45.5 
CTA 7.5 38.5 176_0 
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associated with the graft's chronic rejection. The fact that a 
bone marrow containing allograft recipient undergoes a 
continuum of mild, self-limited GVH, graft prolongation. 
and eventual chronic rejection suggests that the establish-
ment of tolerance within a chimeric system is dynamic 
rather than deletional and responds to mutually interacting 
donor and host-derived elements. 
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